JW Pharmaceutical, Kazakh firm sign MOU for amino acid infusions plant

Published: 2011-08-30 06:58:00

Updated: 2011-08-30 06:58:00

JW Pharmaceutical Corp. Friday signed a memorandum of understanding (MOU) with Kazakhstan's largest pharmaceutical firm JSC Chempharm for a feasibility study on building an amino acid solutions plant.

Together with JSC, JW will research and analyze possible construction sites, technology, equi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK